Section
Prospective cohort data from Switzerland reveal that elevated sFlt-1/PlGF ratios at term correlate with shorter time to spontaneous delivery in low-risk pregnancies, while PlGF declines and sFlt-1 rises from term to post-term. These finding
A prospective study evaluating at-home stool collection for gut microbiome research in gynecologic oncology demonstrates implementation feasibility with 61% patient enrollment. Provider engagement emerged as the strongest predictor of parti
This review synthesizes recent evidence on pregnancy-related anemia, highlighting a 25.6% US prevalence, the clinical significance of iron deficiency without anemia (IDWA), and the critical impact on maternal-fetal outcomes and cardiovascul
A randomized controlled trial demonstrates that performing oral glucose tolerance tests before hospital discharge significantly improves screening rates and patient satisfaction compared to standard outpatient care for women with gestationa
This review analyzes a landmark machine learning study identifying four distinct GDM phenotypic clusters, revealing that early-diagnosed, comorbidity-related GDM carries a four-fold higher risk of postpartum diabetes.
This review synthesizes recent qualitative and clinical evidence regarding the linguistic barriers between gynaecology providers and patients, emphasizing the impact of descriptive terminology on trust, diagnostic clarity, and maternal outc
This review synthesizes new evidence on endometriosis symptom flares, highlighting a significant gap between patient burden and professional guidance, while integrating the latest meta-analytic findings on pharmacologic pain interventions.
This evidence-based review examines the significant disparity in NIH funding for cancer survivorship, revealing that gynecologic cancer research receives nearly five times less funding per survivor than breast cancer research.
This clinical review evaluates the superior efficacy of intravenous ferumoxytol over oral iron for treating gestational anemia, analyzing hematologic recovery and maternal outcomes based on the latest RCT evidence.
This review analyzes the DIP randomized controlled trial, demonstrating that inpatient postpartum glucose testing achieves a 92.3% completion rate compared to 26.9% in outpatient settings, significantly improving detection of prediabetes an
This review synthesizes current evidence on endometrial polyps, focusing on diagnostic accuracy via sonohysterography and the shift toward office-based hysteroscopic polypectomy for abnormal uterine bleeding and infertility.
A large-scale cohort study of premenopausal women demonstrates that adjuvant tamoxifen significantly increases the risk of endometrial cancer, hyperplasia, and polyps, with risk correlating to treatment duration.
This review analyzes the lifestyle patterns of pregnant women with type 1 diabetes, synthesizing findings from the ENDIA study with recent evidence on nutritional adequacy, islet autoimmunity, and the molecular mechanisms of metabolic compe
The Phase 3 SONIA trial demonstrates that delaying CDK4/6 inhibitors to the second-line setting for advanced breast cancer yields comparable overall survival to first-line use, while significantly reducing treatment-related toxicities and h
This review analyzes the LIDA trial findings, demonstrating that an abbreviated 3-month romosozumab course followed by denosumab is non-inferior to the standard 12-month regimen in increasing total hip bone mineral density, potentially redu
This review evaluates the LIDA trial’s findings that 3 months of romosozumab followed by denosumab is non-inferior to 12 months of romosozumab, offering a cost-effective strategy to mitigate long-term side effects.
This clinical review synthesizes findings from the PRETHYR study on antithyroid drug use in pregnant women, highlighting treatment transitions, biochemical predictors, and the impact of specialist-led management in Denmark.
A prespecified secondary analysis of the J-START trial reveals that adding ultrasonography to mammography for women aged 40-49 significantly reduces the long-term cumulative incidence of advanced breast cancer, particularly in populations w
A Danish cohort study demonstrates that specific pregnancy biomarkers, particularly sFlt-1 and hs-cTnI measured at 29 weeks, significantly enhance the prediction of long-term cardiovascular disease risk in women, independent of traditional
The PREVENT-PE trial demonstrates that risk-stratified scheduled birth at 37–38 weeks reduces pre-eclampsia incidence by 30% without increasing neonatal morbidity or emergency cesarean sections, offering a new standard for late-pregnancy ma
